Prof Brendan Jenkins
Laboratory Head
Centre for Innate Immunity and Infectious Diseases
Hudson Institute of Medical Research
brendan.jenkins@monash.edu
Research Activities
In vivo models assessing the mechanisms by which imbalanced STAT1 and STAT3 signalling from the IL-6 cytokine family common receptor gp130 contribute to inflammation, tumourigenesis, dysregulated lympho-hematopoiesis and bone metabolismTechniques/Expertise
Gene targeting, mammalian cell culture techniques, immuno-detection techniques (eg immunohistochemistry, ELISA, Western blotting, flow cytometry), quantitative RT-PCR analysesCollaborations
Simon Jones/Nicholas Topley (Cardiff, UK)Andrew Robers (WEHI, Melbourne)
Matthias Ernst (Ludwig, Melbourne)
Robyn Starr (St Vincents Institute, Melbourne)
Matthew Gillespie and Jack Martin (St Vincents Institute, Melbourne)
Jane Armes (Mater Hospital, Brisbane)
